Announcements

  • Findings indicate two newest TB drugs, bedaquiline and delamanid in combination safe, promising for

    7 years ago
    A study following outcomes of 28 patients with drug-resistant tuberculosis in three countries with high burdens of the disease found what the researchers cite as strong evidence that a combination of the two newest TB drugs could be part of a safe and effective treatment regimen.